共 50 条
- [32] Cost-effectiveness Considerations of Cardiovascular Therapeutics [J]. HEART LUNG AND CIRCULATION, 2009, 18 (02): : 118 - 122
- [35] Cost-effectiveness analysis in infectious diseases [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (12) : 1705 - 1706
- [36] Cost-Effectiveness of Biologics for Allergic Diseases [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (03): : 1107 - +
- [37] The Economic Burden of Somatization Syndromes: A Systematic Review of Cost-Of-Illness Studies and Cost-Effectiveness Analyses [J]. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2011, 14 : S16 - S17
- [38] A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies [J]. BMC Pulmonary Medicine, 22
- [39] Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies [J]. FRONTIERS IN NEUROLOGY, 2022, 13
- [40] The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review [J]. PLOS ONE, 2019, 14 (01):